Study reveals how premature menopause increases risk of cardiovascular disease
A new study reveals reveals women with premature menopause often exhibit certain blood cell changes that elevate their risk of developing coronary artery disease.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Dr. Natarajan is the Director of Preventive Cardiology at Massachusetts General Hospital. He received his BA in molecular biology with Honors and Phi Beta Kappa in 2004 from the University of California, Berkeley. He received his MD with Alpha Omega Alpha in 2008 from the University of California, San Francisco. He received his MMSc in biomedical informatics in 2015 from Harvard Medical School. Dr. Natarajan completed his internship and residency in internal medicine at the Brigham and Women's Hospital, Harvard Medical School in 2011. He completed his clinical and research fellowship in cardiovascular medicine at the Massachusetts General Hospital, Harvard Medical School in 2015.
Dr. Natarajan researches the genetic drivers of human atherosclerosis using genetic epidemiology, large-scale sequencing studies, digital health, and genotype-driven human investigation. In addition to his research efforts, Dr. Natarajan is a clinical cardiologist focusing on heart attack prevention, cardiovascular risk reduction, premature heart attack, lipid disorders, and cardiovascular genetics based at the MGH Cardiovascular Disease Prevention Center.
To learn more about Dr. Natarajan's research, please visit http://natarajanlab.mgh.harvard.edu.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Cardiovascular Disease Prevention Center
25 New Chardon Street
Suite 301
Boston, MA 02114-4774
Phone: 617-726-1843
Fax: 617-726-2203
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Atherosclerotic cardiovascular disease, including heart attack, is the leading cause of death in the United States. A large proportion of cardiovascular risk is heritable through known (e.g. lipids, blood pressure) and undiscovered mechanisms. Dr. Natarajan leverages natural human genetic variation, biomarkers, human physiology, and digital health to: 1) understand the biology of atherosclerosis in humans; 2) identify new therapeutic targets to reduce cardiovascular risk; 3) predict risk for developing a heart attack; and 4) identify individuals who may benefit from tailored preventive strategies.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.
A new study reveals reveals women with premature menopause often exhibit certain blood cell changes that elevate their risk of developing coronary artery disease.
在本次问答中,医学博士及心脏病学研究员 Jay Khambhati、注册护士及临床研究护士 Tinamarie Desmarais、注册护士、理科硕士、美国心血管和肺康复协会 (AACVPR)成员及联合主席Kathleen C. Traynor,以及医学博士、医学硕士、心血管疾病预防中心联合主席 Pradeep Natarajan 将会介绍存在心血管疾病风险的患者应如何在新型冠状病毒大流行期间保持健康。
Elevated levels of a little-known lipoprotein in the blood that may put people at high risk of cardiovascular disease can be as accurately detected by genetic testing as by conventional laboratory measurement.
En esta entrevista, Jay Khambhati, MD, Tinamarie Desmarais, RN, Kathleen C. Traynor, RN, MS, FAACVPR, y Pradeep Natarajan, MD, MMSc, explican cómo los pacientes con riesgo de enfermedades cardiovasculares pueden mantenerse sanos durante la pandemia del COVID-19.
As the initial surge of the COVID-19 pandemic subsides, Massachusetts General Hospital leaders are discussing the transition to strategies for recovery and wellness.